Neuropeptide Y in the Rabbit Maxillary Sinus Modulates Cholinergic Acceleration of Mucociliary Activity

References

• Uddman R, Sundler F, Emson P. Occurrence and distribution of neuropeptide-Y-immunoreactive nerves in the respiratory tract and middle ear. Cell Tissue Res 1984; 237: 321–7
   PubMed Web of Science ®Google Scholar
• Lacroix J S, Änggard A, Hökfelt T, O'Hare M MT, Fahrenkrug J, Lundberg JM. Neuropeptide Y: presence in sympathetic and parasympathetic innervation of the nasal mucosa. Cell Tissue Res 1990; 259: 119–28
   PubMed Web of Science ®Google Scholar
• Lundberg J M, Terenius L, Hökfelt T, Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 1983; 42: 167–72
   PubMed Web of Science ®Google Scholar
• Ekblad E, Edvinsson L, Wahlestedt C, Uddman R, Håkanson R, Sundler F. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept 1984; 8: 225–35
   PubMed Web of Science ®Google Scholar
• Lundberg J M, Rudehill A, Sollevi A, Theodorsson-Norheim E, Hamberger B. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett 1986; 63: 96–100
   PubMed Web of Science ®Google Scholar
• Lacroix J S, Stjäme P, Änggård A, Lundberg JM. Sympathetic vascular control of the pig nasal mucosa (III): co-release of noradrenaline and neuropeptide Y. Acta Physiol Scand 1989; 135: 17–28
   PubMedGoogle Scholar
• Lundblad L, Ånggård A, Saria A., Lundberg JM. Neuropeptide Y and non-adrenergic sympathetic vascular control of the cat nasal mucosa. J Auton Nerv Syst 1987; 20: 189–97
   PubMedGoogle Scholar
• Lacroix J S, Stjärne P, Änggård A, Lundberg JM. Sympathetic vascular control of the pig nasal mucosa (2): reserpine-resistant non-adrenergic nervous responses in relation to neuropeptide Y and ATP. Acta Physiol Scand 1988; 133: 183–97
   PubMedGoogle Scholar
• Cervin A, Lindberg S., Mercke U. The effect of neuropeptide Y on mucociliary activity in the rabbit maxillary sinus. Acta Otolaryngol (Stockh) 1991; 111: 960–6
   PubMed Web of Science ®Google Scholar
• Sundler F, Ekblad E, Grunditz T, Hakanson R, Uddman R. Vasoactive intestinal peptide in the peripheral nervous system. Ann NY Acad Sci 1988; 527: 143–67
   PubMedGoogle Scholar
• Stretton C D, Barnes PJ. Modulation of cholinergic neurotransmission in guinea-pig trachea by neuropeptide Y. Br J Pharmacol 1988; 93: 672–8
   PubMed Web of Science ®Google Scholar
• Matran R, Martling C R, Lundberg JM. Inhibition of cholinergic and non-adrenergic non-cholin-ergic bronchoconstriction in the guinea pig mediated by neuropeptide Y and alpha2-adrenoceptors and opiate receptors. Eur J Pharmacol 1989; 163: 15–23
   PubMed Web of Science ®Google Scholar
• Lindberg S, Hybbinette J-C, Mercke U. Effects of nicotine bitartrate on mucociliary activity. Eur J Respir Dis 1985; 66: 40–6
   PubMedGoogle Scholar
• Coons AH. Fluorescent antibody methods. General cytochemical methods, JF Danielli. Academic Press, New York 1958; Vol. I: 399–422
   Google Scholar
• Hybbinette J-C, Mercke U. A method for evaluating the effect of pharmacological substances on mucociliary activity in vivo. Acta Otolaryngol (Stockh) 1982; 93: 151–9
   PubMed Web of Science ®Google Scholar
• Tenland T. On laser doppler flowmetry. Methods and microvascular applications [Medical Dissertation No. 136]. Thesis. Linkoping University, Sweden 1982
   Google Scholar
• Hybbinette J C, Mercke U. Effects of the parasympathomimetic drug methacholine and its antagonist atropine on mucociliary activity. Acta Otolaryngol (Stockh) 1982; 93: 465–73
   PubMed Web of Science ®Google Scholar
• Schindelmeiser J, Addicks H W, Addicks K. Innervation of the mucosa of rabbit maxillary sinus. II. Demonstration of catecholamine fluorescence and acetylcholinesterase activity. Acta Otolaryngol (Stockh) 1982; 94: 531–6
   PubMed Web of Science ®Google Scholar
• Tenmoku S, Ottesen B, O'Hare M MT, Hilsted L, Johnsen A, Schwartz TW. Interaction of NPY and VIP in regulation of myometrial blood flow and mechanical activity. Peptides 1988; 9: 269–75
   PubMed Web of Science ®Google Scholar
• Grundemar L, Widmark E, Waldeck B, Håkanson R. Neuropeptide Y: prejunctional inhibition of vagally induced contractions in the guinea pig trachea. Regul Pept 1988; 23: 309–13
   PubMedGoogle Scholar
• Lindberg S, Cervin A, Mercke U., Uddman R. VIP potentiates cholinergic effects on the mucociliary system in the maxillary sinus. Otolaryngol Head Neck Surg 1988; 99: 401–7
   PubMed Web of Science ®Google Scholar
• Webber SE. The effects of peptide histidine isoleucine and neuropeptide Y on mucus volume output from the ferret trachea. Br J Pharmacol 1988; 95: 49–54
   PubMed Web of Science ®Google Scholar
• Hoist J J, Fahrenkrug J., Knuhtsen S. VIP and PHI in the pig pancreas: coexistence corelease and cooperative effects. Am J Physiol 1987; 252: 182–9
   PubMed Web of Science ®Google Scholar
• Hoist J J, Orskov C, Knuhtsen S, Sheikh S, Nielsen OV. On the regulatory functions of neuropeptide Y (NPY) with respect to vascular resistance and exocrine and endocrine secretion in the pig pancreas. Acta Physiol Scand 1989; 136: 519–26
   PubMedGoogle Scholar
• Lindberg S, Dolata J, Mercke U. Nasal exposure to airway irritants triggers a mucociliary defence reflex in the rabbit maxillary sinus. Acta Otolaryngol (Stockh) 1987; 104: 552–60
   PubMed Web of Science ®Google Scholar